Scilex Holding Company Other Nonoperating Expense
Scilex Holding Company (SCLX) reported Other Nonoperating Expense of $21.96 million for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Income Statement › Other Income
us-gaap:OtherNonoperatingExpense · last filed 2024-08-13
- Scilex Holding Company other nonoperating expense for the quarter ending 2024-06-30 was $21.96M, a 472.15% increase year-over-year.
- Scilex Holding Company other nonoperating expense for the quarter ending 2024-03-31 was $4.90M, a 7.08% decline year-over-year.
- Scilex Holding Company other nonoperating expense for the quarter ending 2023-06-30 was $3.84M.
- Scilex Holding Company other nonoperating expense for the quarter ending 2023-03-31 was $5.27M.
| Period end | Other Nonoperating Expense 3 month | Other Nonoperating Expense 6 month |
|---|---|---|
| 2024-06-30 | $21.96M 10-Q · filed 2024-08-13 | $26.86M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $4.90M 10-Q · filed 2024-05-13 | |
| 2023-06-30 | $3.84M 10-Q · filed 2024-08-13 | $9.11M 10-Q · filed 2024-08-13 |
| 2023-03-31 | $5.27M 10-Q · filed 2024-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |